|
URB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.600800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.189900E-04 |
| Normal-vs-Stage2 |
4.132000E-02 |
| Normal-vs-Stage3 |
7.995600E-01 |
| Normal-vs-Stage4 |
9.088600E-01 |
| Stage1-vs-Stage2 |
8.934600E-01 |
| Stage1-vs-Stage3 |
1.192430E-02 |
| Stage1-vs-Stage4 |
1.012840E-01 |
| Stage2-vs-Stage3 |
9.026000E-02 |
| Stage2-vs-Stage4 |
1.545600E-01 |
| Stage3-vs-Stage4 |
9.512400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.662600E-03 |
| Normal-vs-AfricanAmerican |
4.804800E-03 |
| Normal-vs-Asian |
4.397800E-01 |
| Caucasian-vs-AfricanAmerican |
4.692600E-01 |
| Caucasian-vs-Asian |
9.672400E-01 |
| AfricanAmerican-vs-Asian |
8.195600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.773000E-04 |
| Normal-vs-Female |
8.169200E-01 |
| Male-vs-Female |
2.858700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.587900E-02 |
| Normal-vs-Extreme_Weight |
2.160400E-04 |
| Normal-vs-Obese |
1.723960E-01 |
| Normal-vs-Extreme_Obese |
6.209900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.358000E-01 |
| Normal_Weight-vs-Obese |
5.861800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.996200E-01 |
| Extreme_Weight-vs-Obese |
7.909800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.436800E-01 |
| Obese-vs-Extreme_Obese |
5.648400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.615000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.553900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.818900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.18680000005256E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.573800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.937850E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.617200E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.106010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.641300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.538300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.362100E-04 |
| Normal-VS-Type2 PRCC |
3.156100E-02 |
| Normal-VS-KIRP CIMP |
4.581800E-02 |
| Normal-VS-Unclassified PRCC |
3.341200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.891600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.34210000005231E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.842000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.237500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.861400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.275700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.574000E-04 |
| Normal-vs-N1 |
1.399440E-01 |
| Normal-vs-N2 |
8.891600E-01 |
| N0-vs-N1 |
2.621500E-03 |
| N0-vs-N2 |
2.911800E-01 |
| N1-vs-N2 |
4.659000E-01 |
|
|
